SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,085 | -99.9% | 8,370 | -31.6% | 0.11% | -4.4% |
Q1 2022 | $956,000 | +231.9% | 12,240 | +229.9% | 0.11% | +289.7% |
Q2 2021 | $288,000 | -67.7% | 3,710 | -50.4% | 0.03% | -80.1% |
Q1 2019 | $891,000 | +217.1% | 7,478 | +97.2% | 0.15% | +247.6% |
Q1 2018 | $281,000 | +28.9% | 3,792 | -41.3% | 0.04% | +2.4% |
Q2 2017 | $218,000 | +4.3% | 6,462 | -8.2% | 0.04% | -16.3% |
Q1 2017 | $209,000 | – | 7,038 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |